NEUROMARK
Latest round
- Series C
Last raised
- Feb 2026
Total raised
- $103M
Investors
- 10
About NEUROMARK
Based in Ireland, Neurent Medical Ltd.Neurent Medical Ltd. is a medical technology company that focuses on chronic rhinitis treatment solutions. Neurent Medical Ltd. is a medical technology company that focuses on chronic rhinitis treatment solutions. Based in Galway, Ireland, Neurent Medical was co-founded by Brian Shields and as of 2026 he is serving as CEO. In February 2026, Neurent Medical Ltd. Neurent Medical specializes in the NEUROMARK® System, an advanced device that employs proprietary radiofrequency technology to create lesions that interrupt posterior nasal nerves, alleviating the symptoms of chronic rhinitis. The system is designed for Otolaryngologists, enhancing treatment precision and patient comfort, and is applicable for both newly diagnosed and chronic rhinitis patients. Neurent Medical generates revenue through direct sales of the NEUROMARK® System and related treatment supplies to healthcare institutions and practitioners. The business operates on a B2B model where healthcare providers purchase the system as part of treatment protocols for chronic rhinitis. Revenue is derived from the sale of the device and potential ongoing partnerships for consumable supplies and training services. The company also intends to explore new markets, focusing on expanding its presence in regions where the demand for chronic rhinitis treatments is growing. Specific details on upcoming product launches and market expansion dates have not been disclosed.
Who invested in NEUROMARK
10 investors across 4 rounds
See all investors in NEUROMARK
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about NEUROMARK
Who invested in NEUROMARK?
NEUROMARK has 10 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has NEUROMARK raised?
NEUROMARK has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did NEUROMARK last raise money?
NEUROMARK's most recent round on record is a Series C, in Feb 2026.
What does NEUROMARK do?
Based in Ireland, Neurent Medical Ltd.
Where is NEUROMARK headquartered?
NEUROMARK is headquartered in Braintree, US.
Which VCs invest in companies like NEUROMARK?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at NEUROMARK's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series C
Raising like NEUROMARK? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.